MAFFIOLI, MARGHERITA
MAFFIOLI, MARGHERITA
Everolimus in diffuse large B-cell lymphomas
2015-01-01 Merli, Michele; Ferrario, Andrea; Maffioli, Margherita; Arcaini, Luca; Passamonti, Francesco
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project.
2018-01-01 Barraco, D; Mora, B; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, Jj; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Benevolo, G; Albano, F; Merli, M; Pietra, D; Barbui, T; Rotunno, G; Cazzola, M; Giorgino, T; Vannucchi, Am; Passamonti, F.
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group.
2020-01-01 Mora, B; Guglielmelli, P; Rumi, E; Maffioli, M; Barraco, D; Rambaldi, A; Caramella, M; Komrokji, Rs; Kiladjian, Jj; Gotlib, J; Iurlo, A; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Albano, F; Benevolo, G; Cavalloni, C; Uccella, S; Accetta, R; Siracusa, C; Agnoli, S; Merli, M; Barbui, T; Bertù, L; Cazzola, M; Vannucchi, Am; Passamonti, F.
Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphoma
2015-01-01 Merli, Michele; Ferrario, Andrea; Maffioli, Margherita; Arcaini, Luca; Passamonti, Francesco
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis
2016-01-01 Breccia, Massimo; Graffigna, Guendalina; Galimberti, Sara; Iurlo, Alessandra; Pungolino, Ester; Pizzuti, Michele; Maggi, Alessandro; Falzetti, Franca; Capalbo, Silvana Franca; Intermesoli, Tamara; Maffioli, Margherita; Elena, Chiara; Melosi, Alessandro; Simonetti, Federico; Capochiani, Enrico; Seta, Roberta Della; Pacilli, Matteo; Luppi, Mario; Di Renzo, Nicola; Mastrullo, Lucia; Trabacchi, Elena; Vallisa, Daniele; Rapezzi, Davide; Orlandi, Ester Maria; Gambacorti Passerini, Carlo; Efficace, Fabio; Alimena, Giuliana
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia.
2018-01-01 Mora, B; Giorgino, T; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, Jj; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Benevolo, G; Albano, F; Cavalloni, C; Barraco, D; Pietra, D; Barbui, T; Rotunno, G; Vannucchi, Am; Passamonti, F
Platelet count predicts driver mutations’ co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis
In corso di stampa Mora, B.; Siracusa, C.; Rumi, E.; Maffioli, M.; Casetti, I. C.; Barraco, D.; Merli, M.; Rossi, M.; Ubezio, M.; Accetta, R.; Libera, L.; Pietra, D.; Trotti, C.; Uccella, S.; Pallotti, F.; Casalone, R.; Bertu, L.; Arcaini, L.; Della Porta, M. G.; Passamonti, F.
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project.
2018-01-01 Mora, B; Giorgino, T; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, Jj; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Benevolo, G; Albano, F; Cavalloni, C; Barraco, D; Merli, M; Pietra, D; Casalone, R; Barbui, T; Rotunno, G; Cazzola, M; Vannucchi, Am; Passamonti, F.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Everolimus in diffuse large B-cell lymphomas | 1-gen-2015 | Merli, Michele; Ferrario, Andrea; Maffioli, Margherita; Arcaini, Luca; Passamonti, Francesco | |
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project. | 1-gen-2018 | Barraco, D; Mora, B; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, Jj; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Benevolo, G; Albano, F; Merli, M; Pietra, D; Barbui, T; Rotunno, G; Cazzola, M; Giorgino, T; Vannucchi, Am; Passamonti, F. | |
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. | 1-gen-2020 | Mora, B; Guglielmelli, P; Rumi, E; Maffioli, M; Barraco, D; Rambaldi, A; Caramella, M; Komrokji, Rs; Kiladjian, Jj; Gotlib, J; Iurlo, A; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Albano, F; Benevolo, G; Cavalloni, C; Uccella, S; Accetta, R; Siracusa, C; Agnoli, S; Merli, M; Barbui, T; Bertù, L; Cazzola, M; Vannucchi, Am; Passamonti, F. | |
Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphoma | 1-gen-2015 | Merli, Michele; Ferrario, Andrea; Maffioli, Margherita; Arcaini, Luca; Passamonti, Francesco | |
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis | 1-gen-2016 | Breccia, Massimo; Graffigna, Guendalina; Galimberti, Sara; Iurlo, Alessandra; Pungolino, Ester; Pizzuti, Michele; Maggi, Alessandro; Falzetti, Franca; Capalbo, Silvana Franca; Intermesoli, Tamara; Maffioli, Margherita; Elena, Chiara; Melosi, Alessandro; Simonetti, Federico; Capochiani, Enrico; Seta, Roberta Della; Pacilli, Matteo; Luppi, Mario; Di Renzo, Nicola; Mastrullo, Lucia; Trabacchi, Elena; Vallisa, Daniele; Rapezzi, Davide; Orlandi, Ester Maria; Gambacorti Passerini, Carlo; Efficace, Fabio; Alimena, Giuliana | |
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia. | 1-gen-2018 | Mora, B; Giorgino, T; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, Jj; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Benevolo, G; Albano, F; Cavalloni, C; Barraco, D; Pietra, D; Barbui, T; Rotunno, G; Vannucchi, Am; Passamonti, F | |
Platelet count predicts driver mutations’ co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis | In corso di stampa | Mora, B.; Siracusa, C.; Rumi, E.; Maffioli, M.; Casetti, I. C.; Barraco, D.; Merli, M.; Rossi, M.; Ubezio, M.; Accetta, R.; Libera, L.; Pietra, D.; Trotti, C.; Uccella, S.; Pallotti, F.; Casalone, R.; Bertu, L.; Arcaini, L.; Della Porta, M. G.; Passamonti, F. | |
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project. | 1-gen-2018 | Mora, B; Giorgino, T; Guglielmelli, P; Rumi, E; Maffioli, M; Rambaldi, A; Caramella, M; Komrokji, R; Gotlib, J; Kiladjian, Jj; Cervantes, F; Devos, T; Palandri, F; De Stefano, V; Ruggeri, M; Silver, Rt; Benevolo, G; Albano, F; Cavalloni, C; Barraco, D; Merli, M; Pietra, D; Casalone, R; Barbui, T; Rotunno, G; Cazzola, M; Vannucchi, Am; Passamonti, F. |